ALB vs CODX · $8.00B cap vs rev $3.9M
Albemarle Corp (ALB) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
ALB does not have a complete income-statement cache yet.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
ALB currently screens at market cap $8.00B. CODX currently screens at market cap $31.4M.
Not investment advice. Open the ALB and CODX stock pages for the full models.
Not investment advice.